The Efficacy and Safety of Infliximab Therapy for Refractory Kawasaki Disease in Infants. Furuta T, Yasudo H, Ohnishi Y, Miyake A, et al. Pediatr Infect Dis J 2020 Apr 2. doi: 10.1097/INF.0000000000002677.

Read + Share

Amedeo Smart

Independent Medical Education

Furuta T, Yasudo H, Ohnishi Y, Miyake A, et al. The Efficacy and Safety of Infliximab Therapy for Refractory Kawasaki Disease in Infants. Pediatr Infect Dis J 2020 Apr 2. doi: 10.1097/INF.0000000000002677.
PMID: 32251260